Form 8-K - Current report:
SEC Accession No. 0001558370-25-001016
Filing Date
2025-02-14
Accepted
2025-02-14 16:35:12
Documents
15
Period of Report
2025-02-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K glyc-20250214x8k.htm   iXBRL 8-K 59041
2 EX-10.1 glyc-20250214xex10d1.htm EX-10.1 71045
3 EX-10.2 glyc-20250214xex10d2.htm EX-10.2 509786
  Complete submission text file 0001558370-25-001016.txt   871367

Data Files

Seq Description Document Type Size
4 EX-101.SCH glyc-20250214.xsd EX-101.SCH 3663
5 EX-101.LAB glyc-20250214_lab.xml EX-101.LAB 15361
6 EX-101.PRE glyc-20250214_pre.xml EX-101.PRE 10380
17 EXTRACTED XBRL INSTANCE DOCUMENT glyc-20250214x8k_htm.xml XML 4642
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36177 | Film No.: 25629890
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)